IMMUNE CHECKPOINT INHIBITION

Clinical trials for IMMUNE CHECKPOINT INHIBITION explained in plain language.

Never miss a new study

Get alerted when new IMMUNE CHECKPOINT INHIBITION trials appear

Sign up with your email to follow new studies for IMMUNE CHECKPOINT INHIBITION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Radiation blast may supercharge cancer drugs in small trial

Disease control Ongoing

This study is testing if giving targeted, high-dose radiation to cancer spots before starting immunotherapy drugs makes the drugs work better for people with advanced stomach or esophageal cancer. It's a small, early-stage safety trial for patients whose cancer has spread but is …

Matched conditions: IMMUNE CHECKPOINT INHIBITION

Phase: PHASE1, PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control

Last updated Mar 11, 2026 14:52 UTC

IMMUNE CHECKPOINT INHIBITION

Get alerted when new IMMUNE CHECKPOINT INHIBITION trials appear

Radiation blast may supercharge cancer drugs in small trial